German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023
Regulatory compliance is no longer the only pressing issue for medtechs in Germany
While revenues are looking healthier at last, a host of issues in the post-COVID readjustment phase still weigh heavily on medtech manufacturers in Germany, chief among which is EU and national over-regulation. Hospital reform and the digital shift are also on a long list of priority issues to monitor and tackle if Germany’s industrial base is to remain preeminent, said BVMed chief executive Marc-Pierre Möll.
